Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.

Area of Science:

• Neuroscience
• Pharmacology
• Radiochemistry

Background:

• Parkinson's disease (PD) involves degeneration of the nigrostriatal dopaminergic system.
• 6-hydroxydopamine (6-OHDA) lesions in rats create a hemi-Parkinson's disease model.
• Understanding neurochemical and functional alterations is crucial for PD research.

Purpose of the Study:

• To evaluate the correlation between neurochemical and functional changes in the nigrostriatal dopaminergic system.
• To validate in vivo positron emission tomography (PET) measurements for assessing dopaminergic function in a PD model.
• To establish a molecular pharmacological basis for parkinsonian symptoms.

Main Methods:

• Rats were unilaterally lesioned with 6-hydroxydopamine (6-OHDA).
• In vivo studies included rotational behavior tests (methamphetamine/apomorphine) and PET imaging ([11C]PE2I for dopamine transporters, [11C]raclopride for D2 receptors).
• In vitro autoradiography was performed using the same radioligands.

Main Results:

• Rotational behavior increased with higher 6-OHDA doses.
• [11C]PE2I binding (dopamine transporters) decreased dose-dependently.
• [11C]raclopride binding (D2 receptors) increased dose-dependently.
• Negative correlation between rotations and [11C]PE2I binding; positive correlation between rotations and [11C]raclopride binding.

Conclusions:

• The study demonstrates a robust correlation between neurochemical alterations and functional deficits in a rat PD model.
• In vivo PET imaging is a valid tool for assessing pre- and post-synaptic dopaminergic function.
• These findings provide a molecular pharmacological basis for parkinsonian symptoms.